A detailed history of Resources Investment Advisors, Llc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Resources Investment Advisors, Llc. holds 27,645 shares of AZN stock, worth $1.96 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
27,645
Previous 26,312 5.07%
Holding current value
$1.96 Million
Previous $2.05 Million 4.97%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$76.67 - $87.62 $102,201 - $116,797
1,333 Added 5.07%
27,645 $2.15 Million
Q2 2024

Aug 02, 2024

BUY
$66.81 - $80.83 $995,268 - $1.2 Million
14,897 Added 130.5%
26,312 $2.05 Million
Q1 2024

May 10, 2024

SELL
$61.03 - $69.57 $212,445 - $242,173
-3,481 Reduced 23.37%
11,415 $773,000
Q4 2023

Feb 13, 2024

BUY
$61.89 - $69.28 $330,306 - $369,747
5,337 Added 55.83%
14,896 $1 Million
Q3 2023

Nov 14, 2023

SELL
$64.85 - $71.7 $7,392 - $8,173
-114 Reduced 1.18%
9,559 $647,000
Q2 2023

Aug 07, 2023

BUY
$69.91 - $75.81 $471,962 - $511,793
6,751 Added 231.04%
9,673 $692,000
Q1 2023

May 10, 2023

BUY
$63.15 - $71.6 $184,524 - $209,215
2,922 New
2,922 $202,000
Q4 2018

Feb 12, 2019

SELL
$36.86 - $41.49 $7,372 - $8,298
-200 Closed
0 $0
Q3 2018

Nov 07, 2018

SELL
$34.76 - $39.72 $2,537 - $2,899
-73 Reduced 26.74%
200 $8,000
Q4 2017

Jan 31, 2018

BUY
$32.09 - $34.78 $8,760 - $9,494
273 New
273 $9,000
Q3 2017

Nov 13, 2017

SELL
$28.96 - $34.0 $7,906 - $9,282
-273 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
273
273 $9,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $219B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Resources Investment Advisors, Llc. Portfolio

Follow Resources Investment Advisors, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Resources Investment Advisors, Llc. with notifications on news.